Profile: ProMetic Life Sciences Inc (PLI.TO)

PLI.TO on Toronto Stock Exchange

1.13CAD
25 Jul 2014
Price Change (% chg)

$0.01 (+0.89%)
Prev Close
$1.12
Open
$1.12
Day's High
$1.13
Day's Low
$1.10
Volume
362,641
Avg. Vol
761,700
52-wk High
$1.65
52-wk Low
$0.35

Search Stocks
ProMetic Life Sciences Inc. (ProMetic) is a bio-pharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics, clinical diagnostics, and the elimination of pathogens, The Company focuses its activities in two segments: protein technologies and therapeutics. It develops therapeutics to treat blood-related disorders. Its protein technologies are used to remove pathogens from blood and extract and recover proteins from plasma. The Company is developing products to treat anemia, neutropenia, cancer and autoimmune disease/inflammation. ProMetic uses its Affinity Technology, which employs its Mimetic Ligand technology (chemical hooks that selectively recognize and bind to target biomolecules) to facilitate a variety of applications, where a target biomolecule requires purification or removal. Effective May 9, 2014, the Company raised its interest to 60% from 10% by acquiring a 50% interest in NantPro Biosciences LLC.

Company Address

ProMetic Life Sciences Inc

Bldg 15, 531 Boul. des Prairies
LAVAL   QC   H7V 1B7
P: +1450.7810115
F: +1450.7814477

Search Stocks